D-0180-2021 Class III Terminated
FDA drug recall D-0180-2021 was initiated by Strides Pharma Inc. on Dec 22, 2020 and is designated Class III. Reason for recall: Failed Moisture Limits The recall status is terminated (terminated Jan 26, 2022). Affected quantity: 960 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jan 6, 2021
- Initiation Date
- Dec 22, 2020
- Termination Date
- Jan 26, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 bottles
Product Description
NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816
Reason for Recall
Failed Moisture Limits
Distribution Pattern
PA
Code Information
Lot 7242728A; June 2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0180-2021
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026